12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Clonidine: Phase III start

Next quarter, BioDelivery will begin a placebo-controlled Phase III trial of clonidine topical gel. BioDelivery is developing the product under section 505(b)(2) of the Food, Drug and Cosmetic Act, which allows...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >